Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
Open Access
- 1 November 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 2 (11) , e1914689
Abstract
Diabetes and prostate cancer are 2 very common conditions affecting older men. General practitioners are often involved in the diagnosis and management of both diseases.Keywords
This publication has 38 references indexed in Scilit:
- Changes in serum prostate‐specific antigen levels and the identification of prostate cancer in a large managed care populationBJU International, 2013
- Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥12)‐core prostate biopsyThe Prostate, 2011
- The effect of demographic and clinical factors on the relationship between BMI and PSA levelsThe Prostate, 2011
- Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?Prostate Cancer and Prostatic Diseases, 2010
- Does pre-existing diabetes affect prostate cancer prognosis? A systematic reviewProstate Cancer and Prostatic Diseases, 2009
- Association of Diabetes With Prostate Cancer Risk in the Multiethnic CohortAmerican Journal of Epidemiology, 2009
- Diabetes mellitus and risk of prostate cancer in the health professionals follow‐up studyInternational Journal of Cancer, 2008
- Serum Prostate-Specific Antigen Levels in Men With Type 2 DiabetesDiabetes Care, 2008
- Prostate-specific Antigen Values in Diabetic and Nondiabetic US Men, 2001–2002American Journal of Epidemiology, 2006
- Obesity and prostate cancer screening among african-american and caucasian menThe Prostate, 2006